Did you know that 50% of cancers are preventable? I didn’t. As her PSA, Kathy also implores all listeners who may today or someday face a cancer diagnosis – get a second opinion on that pathology report. From her work she states this particular area is still equal parts art and science in medicine – and while AI may change that in the future – today the second opinion could be life altering.
Hear Kathy talk about:
-How she has chosen when to move to a next career opportunity (spoiler alert, the answer comes down to learning and also thinking about opportunity for impact).
-What has changed over the years with technology. The advancement of the data science toolsets today is phenomenal. The question remains as to how this can shorten innovation adoption cycles.
-Her optimism in how data tooling and patient focused solutions can actually impact patients – better patient communication, real time communication with physicians. And with the potential to both prevent adverse events today – with promise to move to prevention.
*****************************
Ford is responsible for the ideation, development and commercialization of Ronin, a provider of cutting-edge clinical intelligence software and AI services that helps clinicians understand the context between data points for patients undergoing oncology treatment. Ford has a long history in leading and bringing innovative technology to market at Rhinogram, GE Healthcare, Siemens Medical, McKesson and NantHealth.